← Back to Search

Synthetic Bone Graft Material

Amplex (synthetic bone graft) for Fungal Arthritis

Phase 1 & 2
Waitlist Available
Led By Mark Glazebrook, MD
Research Sponsored by BioSurface Engineering Technologies, Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9-12 months
Awards & highlights
No Placebo-Only Group

Summary

The current research study evaluates an investigational medical device called Amplex B2A(TM) Peptide Enhanced Ceramic Granules ("Amplex") for use in foot and ankle fusion. Amplex is a synthetic bone graft material. The most frequently used graft material is bone collected from the patient (autograft). Autograft involves a secondary incision with the risks of infection and lasting pain. The purpose of this study is to determine if Amplex is a safe and effective alternative to autograft.

Eligible Conditions
  • Fungal Arthritis
  • Arthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9-12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 9-12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Ankle Osteoarthritis Questionnaire
Radiographic fusion
Various blood tests

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Amplex (synthetic bone graft)Experimental Treatment1 Intervention
Group II: Autograft boneActive Control1 Intervention

Find a Location

Who is running the clinical trial?

BioSurface Engineering Technologies, IncLead Sponsor
2 Previous Clinical Trials
46 Total Patients Enrolled
Mark Glazebrook, MDPrincipal InvestigatorQueen Elizabeth II Health Sciences Center Halifax Infirmary
1 Previous Clinical Trials
250 Total Patients Enrolled
David M Hooper, PhDStudy DirectorBioSurface Engineering Technologies, Inc
1 Previous Clinical Trials
22 Total Patients Enrolled
~2 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top